Mar­ket­ingRx roundup: Ab­b­Vie de­buts Vray­lar cam­paign for de­pres­sion; Amy­lyx re-ups “Get Inked” for ALS ef­fort

In De­cem­ber, Ab­b­Vie re­ceived a fourth in­di­ca­tion for Vray­lar as an add-on to an­ti­de­pres­sants for the treat­ment of ma­jor de­pres­sive dis­or­der – and now it …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER